Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells.
Abstact
No abstract available.
Authors
- Blomquist TM
- Craig DJ
- Crawford EL
- Khuder SA
- Morrison T
- Willey JC
- Wu L
- Xu J